ArticleCancer research2022

WNT5A-RHOA Signaling Is a Driver of Tumorigenesis and Represents a Therapeutically Actionable Vulnerability in Small Cell Lung Cancer.

Kee-Beom Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.